Iron deficiency in gynecology and obstetrics: Clinical implications and management

Hematology

Volumn 2017, Issue 1, 2017, Pages 152-159

  Breymann, Christian ^a   Auerbach, Michael ^b,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Auerbach Hematology and Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; BLOOD CELL COUNT; DRUG FORMULATION; GYNECOLOGY; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; OBSTETRICS; PREGNANCY; PUERPERIUM; SYMPTOM; DEFICIENCY; FEMALE; MOBILE APPLICATION; PREGNANCY COMPLICATION; RISK FACTOR; UTERUS BLEEDING;

ANEMIA, IRON-DEFICIENCY; FEMALE; GYNECOLOGY; HUMANS; IRON; MOBILE APPLICATIONS; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RISK FACTORS; UTERINE HEMORRHAGE;

EID: 85038434787     PISSN: 15204391     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2017.1.152     Document Type: Article

References (54)

1. Milman N. Anemia-still a major health problem in many parts of the world!. Ann Hematol. 2011;90(4):369-377.
2. Akabas SR, Dolins K. Micronutrient requirements of physically active women: what can we learn from iron?. Am J Clin Nutr. 2005;81(5): 1246S-1251S.
3. Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynaecol Obstet. 2015; 128(3):196-200.
4. Gao J, Zeng S, Sun BL, Fan HM, Han LH. Menstrual blood loss and hematologic indices in healthy Chinese women. J Reprod Med. 1987; 32(11):822-826.
5. Allen LH. Pregnancy and iron deficiency: Unresolved issues. Nutr Rev. 1997;55(4):91-101.
6. Bencaiova G, Burkhardt T, Breymann C. Anemia-prevalence and risk factors in pregnancy. Eur J Intern Med. 2012;23(6):529-533.
7. Breymann C, Bian XM, Blanco-Capito LR, Chong C, Mahmud G, Rehman R. Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region. J Perinat Med. 2011;39(2):113-121.
8. Hercberg S, Preziosi P, Galan P. Iron deficiency in Europe. Public Health Nutr. 2001;4(2B):537-545.
9. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: Iron deficiency and iron overload. J Clin Pathol. 2011;64(4):287-296.
10. Murray-Kolb L. Maternal mortality, child mortality, perinatal mortality, child cognition, and estimates of prevalence of anemia due to iron deficiency. Child Health Epidemiology Reference Group. Available at: Http://cherg.org/projects/micronutrients.html.
11. Martius F. Eisenmangel ohne Anämie: Ein heisses Eisen [Iron deficiency without anemia: A hot topic]. Swiss Med Wkly. 2009;9(15-16):294-299.
12. Verdon F, Burnand B, Stubi CL, et al. Iron supplementation for unexplained fatigue in non-anaemic women: Double blind randomised placebo controlled trial. BMJ. 2003;326(7399):1124-1128.
13. Beglinger C, Breymann C. Behandlung von Eisenmangel. Wie sind die praktischen Erfahrungen mit oralen und i.v. Eisenpräparaten?. [Therapy of iron deficiency. Practical experience with oral and intravenous iron preparations.] Swiss Med Forum. 2010;10(30):50.
14. Ahmed T. Global Burden of Maternal and Child Undernutrition and Micronutrient Deficiencies. Ann Nutr Metab. 2012;61(suppl 1):8-17.
15. Letsky EA. Anemia. In: James DK, Steer PJ, Weiner CP, Gonik B, eds. High Risk Pregnancy. 2nd ed. London, England: W.B. Saunders; 1999: 729-747.
16. Algarín C, Nelson C, Peirano P, Westerlund A, Reyes S, Lozoff B. Irondeficiency anemia in infancy and poorer cognitive inhibitory control at age 10 years. Dev Med Child Neurol. 2013;55(5):453-8.
17. Bencaiova G, Breymann C. Mild anemia and pregnancy outcome in a Swiss collective. J Pregnancy. 2014;2014:307535.
18. Horowitz KM, Ingardia CJ, Borgida AF. Anemia in pregnancy. Clin Lab Med. 2013;33(2):281-291.
19. Centers for Disease Control (CDC). CDC criteria for anemia in children and childbearing-aged women. MMWR Morb Mortal Wkly Rep. 1989; 38(22):400-404.
20. Breymann C. Iron deficiency and anaemia in pregnancy: Modern aspects of diagnosis and therapy. Blood Cells Mol Dis. 2002;29(3):506-516, discussion 517-521.
21. Gibson RS. Assessment of iron status. Principles of Nutritional Assessment. New York, NY: Oxford University Press; 1990:349-376.
22. Milman N, Graudal N, Agger AO. Iron status markers during pregnancy. No relationship between levels at the beginning of the second trimester, prior to delivery and post partum. J Intern Med. 1995;237(3):261-267.
23. Milman N, Agger AO, Nielsen OJ. Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women. Dan Med Bull. 1991;38(6):471-476.
24. Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, et al. Tolerability of different oral iron supplements: A systematic review. Curr Med Res Opin. 2013;29(4):291-303.
25. Ortiz R, Toblli JE, Romero JD, et al. Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with irondeficiency anemia: A multicenter, randomized, controlled study. J Matern Fetal Neonatal Med. 2011;24(11):1347-1352.
26. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: A systematic review and meta-analysis. PLoS One. 2015;10(2): E0117383.
27. Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J; FERASAP investigators. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: An international, openlabel, randomized controlled trial (FER-ASAP). J Perinat Med. 2017; 45(4):443-453.
28. Myers B, Myers O, Moore J. Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy. Obstet Med. 2012;5(3):105-107.
29. Wong L, Smith S, Gilstrop M, et al. Safety and efficacy of rapid (1, 000 mg in 1 hr) intravenous iron dextran for treatment of maternal iron deficient anemia of pregnancy. Am J Hematol. 2016;91(6):590-593.
30. Hoigné R, Breymann C, Künzi UP, Brunner F. Parenteral iron therapy: Problems and possible solutions [in German]. Schweiz Med Wochenschr. 1998;128(14):528-535.
31. Naim M, Hunter J. Intravenous iron replacement - management in general practice. Aust Fam Physician. 2010;39(11):839-841.
32. Perewusnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. Br J Nutr. 2002;88(1):3-10.
33. Congdon EL, Westerlund A, Algarin CR, et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. J Pediatr. 2012;160(6):1027-1033.
34. Breymann C, Visca E, Huch R, HuchA. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anaemia in pregnancy. Am J Obstet Gynecol. 2001;184(4):662-667.
35. Peña-Rosas J, De-Regil L, Dowswell T, Viteri FE. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2012;12: CD004736.
36. World Health Organization. Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva, Switzerland: WHO Press; 2012.
37. van den Broek N. Anaemia in pregnancy in developing countries. Br J Obstet Gynaecol. 1998;105(4):385-390.
38. Milman N, Jønsson L, Dyre P, Pedersen PL, Larsen LG. Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial. J Perinat Med. 2014;42(2):197-206.
39. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981-1989.
40. Haider B, Olofin I, Wang M, Spiegelmann D, Ezzati M, Fawzi W. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: Systematic review and meta-analysis. BMJ. 2013;346:f3443.
41. Auerbach M, Deloughery T. Single-dose intravenous iron for iron deficiency: A new paradigm. Hematology (Am Soc Hematol Educ Program). 2016;2016(1):57-66.
42. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: Systematic review and metaanalysis. Mayo Clin Proc. 2015;90(1):12-23.
43. Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol. 2002;186(3):518-522.
44. Krafft A, Bencaiova G, Breymann C. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone. Fetal Diagn Ther. 2009;25(2):239-245.
45. Wali A, Mushtaq A, Nilofer. Comparative study-efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. J Pak Med Assoc. 2002;52(9):392-395.
46. Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: Establishing a safe dose. Am J Kidney Dis. 2001;38(5):988-991.
47. Christoph P, Schuller C, Studer H, Irion O, De Tejada BM, Surbek D. Intravenous iron treatment in pregnancy: Comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med. 2012;40(5):469-474.
48. Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: A randomized trial. J Matern Fetal Neonatal Med. 2013;26(7):654-659.
49. Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth. 2014;14:115.
50. Khalafallah AA, Dennis AE. Iron deficiency anaemia in pregnancy and postpartum: Pathophysiology and effect of oral versus intravenous iron therapy. J Pregnancy. 2012;2012:630519.
51. Khalafallah AA, Dennis AE, Ogden K, et al. Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy. BMJ Open. 2012;2(5):e000998.
52. Auerbach M, James SE, Nicoletti M, et al. Results of the first American prospective study of intravenous iron in oral iron-intolerant iron-deficient gravidas [published online ahead of print 21 July 2017]. Am J Med.
53. Auerbach M, Pappadakis JA, Bahrain H, Auerbach SA, Ballard H, Dahl NV. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. Am J Hematol. 2011;86(10):860-862.
54. Ayub R, Tariq N, Adil MM, Iqbal M, Junaid A, Jaferry T. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy. J Coll Physicians Surg Pak. 2008;18(7):424-427.